Literature DB >> 33835427

Identifying key prescribing cascades in older people (iKASCADE): a transnational initiative on drug safety through a sex and gender lens-rationale and design.

Shelley A Sternberg1, Mirko Petrovic2, Graziano Onder3, Antonio Cherubini4, Denis O'Mahony5, Jerry H Gurwitz6, Francesco Pegreffi7, Robin Mason8,9, Jennifer Akerman8, Lisa McCarthy8,10, Andrea Lawson8, Joyce Li8, Wei Wu8, Paula A Rochon11,12,13,14.   

Abstract

PURPOSE: To describe the objectives, methods and expected impact of an international consortium (iKASCADE) whose purpose is to improve drug safety for older adults by addressing prescribing cascades through a sex and gender lens.
METHODS: To create a comprehensive, internationally relevant inventory of prescribing cascades affecting older adults, the consortium has created a modified Delphi procedure where international experts in prescribing and managing pharmacotherapy for older adults will rank a list of prescribing cascades as to their clinical importance. We will use administrative and clinical data on older adults to evaluate the frequency of prescribing cascades by sex internationally, in the hospital, long-term care and community settings. Finally, we will use semi-structured interviews and realistic, country-specific vignettes, each incorporating a prescribing cascade with identified sex differences, to explore how socially constructed gender roles contribute to the experience, presentation and management of prescribing cascades.
RESULTS: The consortium will synthesize the quantitative and qualitative results to produce a position paper and products-aimed at knowledge users within and outside of academia-designed to elevate the importance of integrating a gender dimension in the identification and prevention of prescribing cascades.
CONCLUSION: Findings will improve our understanding of how adverse drug events are different between older women and men and inform the development and dissemination of tailored knowledge translation products to reduce the frequency and impact of prescribing cascades.

Entities:  

Keywords:  Older adults; Pharmacotherapy; Prescribing cascades; Sex and gender

Year:  2021        PMID: 33835427     DOI: 10.1007/s41999-021-00480-w

Source DB:  PubMed          Journal:  Eur Geriatr Med        ISSN: 1878-7649            Impact factor:   1.710


  24 in total

1.  Polypharmacy in nursing home in Europe: results from the SHELTER study.

Authors:  Graziano Onder; Rosa Liperoti; Daniela Fialova; Eva Topinkova; Matteo Tosato; Paola Danese; Pietro Folino Gallo; Iain Carpenter; Harriet Finne-Soveri; Jacob Gindin; Roberto Bernabei; Francesco Landi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-01-04       Impact factor: 6.053

2.  Assessing the Scope and Appropriateness of Prescribing Cascades.

Authors:  Lisa M McCarthy; Jessica D Visentin; Paula A Rochon
Journal:  J Am Geriatr Soc       Date:  2019-02-12       Impact factor: 5.562

3.  Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis.

Authors:  Katie Palmer; Emanuele R Villani; Davide L Vetrano; Antonio Cherubini; Alfonso J Cruz-Jentoft; Denis Curtin; Michael Denkinger; Marta Gutiérrez-Valencia; Adalsteinn Guðmundsson; Wilma Knol; Diane V Mak; Denis O'Mahony; Farhad Pazan; Mirko Petrovic; Chakravarthi Rajkumar; Eva Topinkova; Catarina Trevisan; Tischa J M van der Cammen; Rob J van Marum; Martin Wehling; Gijsbertus Ziere; Roberto Bernabei; Graziano Onder
Journal:  Eur Geriatr Med       Date:  2018-11-07       Impact factor: 1.710

Review 4.  What Is Known About Preventing, Detecting, and Reversing Prescribing Cascades: A Scoping Review.

Authors:  Hana Brath; Nishila Mehta; Rachel D Savage; Sudeep S Gill; Wei Wu; Susan E Bronskill; Lynn Zhu; Jerry H Gurwitz; Paula A Rochon
Journal:  J Am Geriatr Soc       Date:  2018-10-18       Impact factor: 5.562

5.  Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe.

Authors:  Luís Midão; Anna Giardini; Enrica Menditto; Przemyslaw Kardas; Elísio Costa
Journal:  Arch Gerontol Geriatr       Date:  2018-06-30       Impact factor: 3.250

6.  The relationship between frailty and polypharmacy in older people: A systematic review.

Authors:  M Gutiérrez-Valencia; M Izquierdo; M Cesari; Á Casas-Herrero; M Inzitari; N Martínez-Velilla
Journal:  Br J Clin Pharmacol       Date:  2018-05-03       Impact factor: 4.335

Review 7.  Clinical consequences of polypharmacy in elderly.

Authors:  Robert L Maher; Joseph Hanlon; Emily R Hajjar
Journal:  Expert Opin Drug Saf       Date:  2013-09-27       Impact factor: 4.250

Review 8.  Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review.

Authors:  Terri R Fried; John O'Leary; Virginia Towle; Mary K Goldstein; Mark Trentalange; Deanna K Martin
Journal:  J Am Geriatr Soc       Date:  2014-12       Impact factor: 5.562

9.  The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010.

Authors:  Bruce Guthrie; Boikanyo Makubate; Virginia Hernandez-Santiago; Tobias Dreischulte
Journal:  BMC Med       Date:  2015-04-07       Impact factor: 8.775

Review 10.  What is polypharmacy? A systematic review of definitions.

Authors:  Nashwa Masnoon; Sepehr Shakib; Lisa Kalisch-Ellett; Gillian E Caughey
Journal:  BMC Geriatr       Date:  2017-10-10       Impact factor: 4.070

View more
  2 in total

1.  "Kind of blurry": Deciphering clues to prevent, investigate and manage prescribing cascades.

Authors:  Barbara Farrell; Emily Galley; Lianne Jeffs; Pam Howell; Lisa M McCarthy
Journal:  PLoS One       Date:  2022-08-31       Impact factor: 3.752

2.  Prescribing cascades in community-dwelling adults: A systematic review.

Authors:  Ann S Doherty; Faiza Shahid; Frank Moriarty; Fiona Boland; Barbara Clyne; Tobias Dreischulte; Tom Fahey; Seán P Kennelly; Emma Wallace
Journal:  Pharmacol Res Perspect       Date:  2022-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.